Isiah Thomas, International Entrepreneur & Philanthropist, Becomes New CEO of Hemp Based Cannabis Company, One World Pharma
04 Junio 2020 - 8:21AM
InvestorsHub NewsWire
One World Pharma Adds
New Leadership as Company Enters Revenue
Phase
LAS VEGAS, NV -- June 4, 2020 -- InvestorsHub
NewsWire -- One World Pharma Inc. (OTC:
OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and
cannabis ingredient producer in Colombia, is pleased to announce
that effective immediately, NBA legend, international entrepreneur
and philanthropist Isiah Thomas has been appointed as its CEO and
Vice-Chairman of the Board of Directors. Mr. Thomas will replace
founder and CEO Craig Ellins who is
retiring.
Isiah Thomas, while
forever known for his Hall of Fame career as a 12-time NBA All
Star, two-time NBA champion, and inclusion as one of the 50
Greatest Players in NBA History, is an accomplished and highly
regarded international business executive and investor with a
portfolio of companies he has developed via Isiah International
Inc. Mr. Thomas has previously served on the Chicago Stock
Exchange’s Board of Governors, was a co-founder of the NBA’s
Toronto Raptors, Popcorn Indiana, and is a member of the Board of
Get-in Chicago, an organization focused on preventing gang violence
in Chicago, since 2013.
His business interests
include sports and entertainment, real estate, waste management,
his cannabis and CBD products company, VESL Oils, and more.
Notably, Mr. Thomas has developed a highly successful champagne
business with Cheurlin Champagnes, where he has cultivated an
excellent relationship with both the grower, employees and the
French government. Mr. Thomas now uniquely owns genetics for the
grapes produced for the champagne and has perfected an
international import/export system for international distribution
of the product.
Mr. Thomas inherits the
reins of an ascendant international hemp and cannabis company which
under Mr. Ellins’ leadership has seen significant development and
progress, including the establishment of highly scalable farm and
production facilities in Colombia, a portfolio of fully registered
elite and government approved genetic strains, and a state
sanctioned THC quota.
The Board of Directors
is grateful to Mr. Ellins and thanks him for his innovation,
dedication, and determination.
“We are elated to
welcome Isiah Thomas to the One World Pharma leadership team and to
have him continue and expand upon the successes of Craig Ellins,”
stated Dr. Kenneth Perego, Executive Chairman of One World Pharma.
“Mr. Thomas is the ideal person to lead us in this new phase as we
commence commercial sales and revenues, lending to our cause his
international business experience, myriad relationships, and
commitment to winning.”
“It is truly an honor
to work with Mr. Thomas on the One World Pharma opportunity and to
leverage his experience in such similar verticals to the benefit of
the Company, its shareholders and our indigenous partners in
Colombia,” added Brian Moore, President, One World
Pharma.
“I am honored to join
One World Pharma and its excellent team. It is a company that
is leading the way in innovation in the hemp and cannabis
industry,” said Isiah Thomas, CEO and Vice-Chairman. “The company’s
deep commitment to excellence in their products and for its
customers positions us well to continue to grow as an international
leader in the industry. Its recognition for its
humanitarian efforts validates its mission as a socially conscious
company in a true partnership with the indigenous
people.”
One World Pharma
Investor Relations & Financial
Media
Integrity
Media
team@integritymedia.com
Toll Free: (888)
216-3595
www.IntegrityMedia.com
Information about
Forward-Looking Statements
This press release
contains "forward-looking statements" that include information
relating to future events. Forward-looking statements should not be
read as a guarantee of future performance or results and will not
necessarily be accurate indications of the times at, or by, which
that performance or those results will be achieved. Forward-looking
statements are based on information available at the time they are
made and/or management's good faith belief as of that time with
respect to future events and are subject to risks and uncertainties
that could cause actual performance or results to differ materially
from those expressed in, or suggested by, the forward-looking
statements. Important factors that could cause these differences
include, but are not limited to: the Company's need for additional
funding, the demand for the Company's products, governmental
regulation of the cannabis industry, the Company's ability to
maintain customer and strategic business relationships, the impact
of competitive products and pricing, risks related to operating in
Colombia, growth in targeted markets, the adequacy of the
Company's liquidity and financial strength to support its growth,
and other risks that may be detailed from time-to-time in the
Company's filings with the United States Securities and Exchange
Commission. For a more detailed description of the risk factors and
uncertainties affecting One World Pharma, please refer to the
Company's Annual Report on Form 10-K filed with the Securities and
Exchange Commission on May 29, 2020, which is available
at www.sec.gov. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events, or
otherwise.
One World Products (QB) (USOTC:OWPC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
One World Products (QB) (USOTC:OWPC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024